Dupixent 200 MG/1.14 ML pen 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FUPNM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,101
Award facts
- Contract value 100% obligated
- $35,100.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $35,100.78 delivery order to AmerisourceBergen Drug Corp for Dupixent 200 mg/1.14 mL pen injectors on July 31, 2025, with completion required by August 1, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor for federal military and veteran healthcare systems.
This delivery order is part of AmerisourceBergen's broader role as a primary pharmaceutical vendor supporting the Defense Health Agency and other federal healthcare programs. The company holds a significant $999.999 billion IDC with DLA Troop Support Medical running through December 2026, which enables supply of a comprehensive range of pharmaceutical products, specialty medications, and medical supplies to support military healthcare operations globally. Dupixent is a biologic treatment commonly used for eczema, asthma, and other allergic inflammatory conditions, reflecting AmerisourceBergen's established capability to deliver specialty pharmaceutical products across multiple therapeutic domains to federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FUPNM?
SPE2DB25FUPNM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FUPNM worth?
The government has obligated $35,101 on SPE2DB25FUPNM.
Is contract SPE2DB25FUPNM an order under another contract?
Yes. SPE2DB25FUPNM is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB25FUPNM competed?
The extent of competition for SPE2DB25FUPNM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award